Genmab A/S (GNMSF) Finished Goods (2023 - 2025)
Genmab A's (GNMSF) quarterly Finished Goods came in at $13.0 million in Q4 2025, up 18.18% YoY from $11.0 million in Q4 2024, and up 18.18% on a QoQ basis from $11.0 million in Q4 2024.
Genmab A/S (GNMSF) Finished Goods (2023 - 2025) Analysis & Trends
Genmab A (GNMSF) has 3 years of Finished Goods data on file, last reported at $13.0 million in Q4 2025.
- Quarterly Finished Goods rose 18.18% year-over-year to $13.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.0 million (up 18.18% YoY) and the FY2025 annual result came in at $13.0 million, up 18.18% from the prior year.
- Finished Goods advanced to $13.0 million in Q4 2025, from $11.0 million in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $13.0 million in Q4 2025 to a low of $9.0 million in Q4 2023.
- A 3-year average of $11.0 million and a median of $11.0 million in 2024 frame the typical range for Finished Goods.
- Annual changes were most pronounced in 2024 — Finished Goods grew 22.22% — and 2025, when it gained 18.18%.
- Tracing GNMSF's Finished Goods over 3 years: stood at $9.0 million in 2023, then climbed by 22.22% to $11.0 million in 2024, then grew by 18.18% to $13.0 million in 2025.
- The last three Finished Goods figures came in at $13.0 million (Q4 2025), $11.0 million (Q4 2024), and $9.0 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.00 Mn |
| Dec 31, 2024 | 11.00 Mn |
| Dec 31, 2023 | 9.00 Mn |